Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Luster

Showing results (101-110 of 181) with videos related to

Pageof 19
Sort By:
Hormones (Athens, Greece)|October 15, 2013
Results of the Thyroid Cancer Alliance international patient/survivor survey: Psychosocial/informational support needs, treatment side effects and international differences in careRita Banach, Beate Bartès, Kate Farnell, et al.
In Vivo (Athens, Greece)|February 24, 2021
Effect of Kinase Inhibitors on the Technetium-99m Uptake into Thyroid Carcinoma Cells <i>In Vitro</i>Anna Anschlag, Brandon H Greene, Lorianna KÖnneker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 18, 2020
New! F-18-based PET/CT for sodium-iodine-symporter-targeted imaging!Frederik A Verburg, Luca Giovanella, Martha Hoffmann, et al.
European Thyroid Journal|January 4, 2022
2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?Furio Pacini, Dagmar Fuhrer, Rossella Elisei, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2018
I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?Frederik A Verburg, Luca Giovanella, Ioannis Iakovou, et al.
Hormones (Athens, Greece)|June 28, 2023
Hypoparathyroidism - management, information needs, and impact on daily living from the patients' perspective: results from a population-based surveyMatthias Büttner, Dieter Krogh, Dagmar Führer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 18, 2020
Higher thyroid hormone levels and cancerPetra Petranović Ovčariček, Frederik A Verburg, Martha Hoffmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2020
Correction to: Higher thyroid hormone levels and cancerPetra Petranović Ovčariček, Frederik A Verburg, Martha Hoffmann, et al.
Journal of Neuroendocrinology|December 29, 2021
Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasmsElisabeth Maurer, Monika Heinzel-Gutenbrunner, Anja Rinke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 25, 2009
Dosimetry-guided high-activity (131)I therapy in patients with advanced differentiated thyroid carcinoma: initial experienceFrederik A Verburg, Heribert Hänscheid, Johannes Biko, et al.
Pageof 19

Showing results (101-110 of 181) with videos related to

Sort By:
Pageof 19
Hormones (Athens, Greece)|October 15, 2013
Results of the Thyroid Cancer Alliance international patient/survivor survey: Psychosocial/informational support needs, treatment side effects and international differences in careRita Banach, Beate Bartès, Kate Farnell, et al.
In Vivo (Athens, Greece)|February 24, 2021
Effect of Kinase Inhibitors on the Technetium-99m Uptake into Thyroid Carcinoma Cells <i>In Vitro</i>Anna Anschlag, Brandon H Greene, Lorianna KÖnneker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 18, 2020
New! F-18-based PET/CT for sodium-iodine-symporter-targeted imaging!Frederik A Verburg, Luca Giovanella, Martha Hoffmann, et al.
European Thyroid Journal|January 4, 2022
2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?Furio Pacini, Dagmar Fuhrer, Rossella Elisei, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2018
I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?Frederik A Verburg, Luca Giovanella, Ioannis Iakovou, et al.
Hormones (Athens, Greece)|June 28, 2023
Hypoparathyroidism - management, information needs, and impact on daily living from the patients' perspective: results from a population-based surveyMatthias Büttner, Dieter Krogh, Dagmar Führer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 18, 2020
Higher thyroid hormone levels and cancerPetra Petranović Ovčariček, Frederik A Verburg, Martha Hoffmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2020
Correction to: Higher thyroid hormone levels and cancerPetra Petranović Ovčariček, Frederik A Verburg, Martha Hoffmann, et al.
Journal of Neuroendocrinology|December 29, 2021
Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasmsElisabeth Maurer, Monika Heinzel-Gutenbrunner, Anja Rinke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 25, 2009
Dosimetry-guided high-activity (131)I therapy in patients with advanced differentiated thyroid carcinoma: initial experienceFrederik A Verburg, Heribert Hänscheid, Johannes Biko, et al.
Pageof 19